Coordination of rare diseases at sanford
NCT ID NCT01793168
First seen Oct 28, 2026 · Last updated Oct 29, 2026 · Updated 1 time
Summary
The Coordination of Rare Diseases at Sanford (CoRDS) is an international patient registry that serves as a centralized resource for rare disease research. Individuals affected by rare diseases, undiagnosed conditions, and disorders of unknown prevalence may voluntarily contribute health information to support natural history studies, participant recruitment, and other research efforts. Through partnerships with patient advocacy organizations and researchers worldwide, CoRDS helps connect rare disease communities with research opportunities while advancing knowledge across more than 7,000 rare diseases. Participation is free of charge.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 20,000 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jul 2010
- Expected to finish
-
Dec 2100
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Unaffected carriers, undiagnosed and those with a rare disease or rare condition.
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Diagnosis of a rare disease, a disease of unknown prevalence, undiagnosed or an unaffected carrier of a rare/uncommon disease Exclusion Criteria: * Diagnosis of a disease which is not rare
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for 1p36 deletion syndrome are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Sanford Health
RECRUITINGSioux Falls, South Dakota, 57104, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Feasibility of whole-body MRI for cancer surveillance in children and young people with ataxia telangiectasia
- Studio pilota Sull'Efficacia della pedana stabilometrica nel trattamento del paziente con atassia di friedreich
- Effects of N-Acetyl-L-Leucine on Ataxia-Telangiectasia (A-T: a phase III, randomized, placebo-controlled, double-blind, crossover study
- Intradermal hyaluronidase for sclerodactyly in systemic sclerosis: a prospective Split-Hand controlled pilot study
- UVA-1 for treatment of skin tightening and improvement of hand function in scleroderma: a randomized, intra-patient, Dominant/Non-dominant hand clinical trial.
- A prospective observational study of neurocognitive function and multimodal brain magnetic resonance imaging in patients with glycogen storage diseases